MedTrace Logo

Effects of Cyclosporine A on Pancreatic Insulin Secretion

NCT00139035 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2012-11-02

No results posted yet for this study

Summary

Our primary aim is to investigate if cyclosporine A reduces insulin secretion.

Conditions

  • Chronic Renal Failure

Interventions

DRUG

cyclosporine A

Sponsors & Collaborators

  • University of Oslo School of Pharmacy

    lead OTHER

Principal Investigators

  • Anders Åsberg, MSc · University of Oslo

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-04-30
Primary Completion
2006-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00139035 on ClinicalTrials.gov